By Eric Sagonowsky
Like a host of other companies, Incyte has been testing one of its existing meds against COVID-19—and that drug, Jakafi, has now fallen short in a phase 3 trial. But the company is forging ahead, saying the new data show enough promise to make the cancer med a viable option for severely ill COVID patients.
read more
By Conor Hale
The FDA granted a breakthrough designation to a neurostimulation device designed to strengthen the diaphragm and help wean people who are having difficulty breathing on their own off of mechanical ventilation.
read more
By Kevin Dunleavy
In Holly Springs, North Carolina, Fujifilm will invest more than $2 billion to build the largest cell culture biopharmaceutical CDMO facility in North America.
read more
By Tina Reed
Fierce Healthcare recently chatted with leaders around the industry about when they first realized the COVID-19 pandemic was going to change everything.
read more
By Robert King
The House passed a bill that gives another extension to a moratorium on a 2% cut to Medicare provider payments installed under sequestration.
read more
By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky,Angus Liu,Conor Hale
The U.S. will send some of its unused AZ vaccine stock to Mexico and Canada. With Europe facing a third coronavirus wave, Germany and France tighten restrictions. Stelis of India will manufacture 200 million doses of the Sputnik V vaccine.
read more
